Gommans Dh Frank, Cramer G Etienne, Bakker Jeannette, Michels Michelle, Dieker Hendrik-Jan, Timmermans Janneke, Fouraux Michael A, Marcelis Carlo Lm, Verheugt Freek Wa, Brouwer Marc A, Kofflard Marcel Jm
Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Radiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Heart. 2017 Feb 15;103(4):293-299. doi: 10.1136/heartjnl-2016-309900. Epub 2016 Aug 9.
Areas of high signal intensity (HighT2) on T2-weighted cardiovascular magnetic resonance (CMR) imaging have been demonstrated in hypertrophic cardiomyopathy (HCM). It has been hypothesised that HighT2 may indicate active tissue injury in HCM. In this context, we studied HighT2 in relation to cardiac troponin.
Outpatient HCM patients without a history of coronary artery disease underwent CMR imaging at 1.5 T using T2-weighted, cine and late gadolinium enhancement (LGE) imaging to assess HighT2, left ventricular (LV) function, LV mass and the presence and extent of LGE. Highly sensitive cardiac troponin T (hs-cTnT) was assessed as a marker of injury, with hs-cTnT ≥14 and >3 ng/L defined as an elevated and detectable troponin.
HighT2 was present in 28% of patients (28/101). An elevated hs-cTnT was present in 54% of patients with HighT2 (15/28) compared with 14% of patients without HighT2 (10/73) (p<0.001). Hs-cTnT was detectable in 96% of patients with HighT2 (27/28) compared with 66% of patients without HighT2 (48/73) (p=0.002). In case of an undetectable hs-cTnT, HighT2 was only seen in 4% (1/26). In addition, the extent of HighT2 was related with increasing hs-cTnT concentrations (Spearman's ρ: 0.42, p<0.001).
In this CMR study of patients with HCM, we observed HighT2 in a quarter of patients, and demonstrated that HighT2 was associated with an elevated hs-cTnT. This observation, combined with the very high negative predictive value of an undetectable hs-cTnT for HighT2, provides supportive evidence for the hypothesis that HighT2 is indicative of recently sustained myocyte injury.
肥厚型心肌病(HCM)患者的T2加权心血管磁共振(CMR)成像上已显示出高信号强度区域(HighT2)。据推测,HighT2可能表明HCM存在活跃的组织损伤。在此背景下,我们研究了与心肌肌钙蛋白相关的HighT2。
无冠心病病史的门诊HCM患者在1.5 T下接受CMR成像,使用T2加权、电影和延迟钆增强(LGE)成像来评估HighT2、左心室(LV)功能、LV质量以及LGE的存在和范围。高敏心肌肌钙蛋白T(hs-cTnT)作为损伤标志物进行评估,hs-cTnT≥14和>3 ng/L定义为肌钙蛋白升高和可检测。
28%的患者(28/101)存在HighT2。HighT2患者中有54%(15/28)的hs-cTnT升高,而无HighT2患者中这一比例为14%(10/73)(p<0.001)。96%的HighT2患者(27/28)可检测到hs-cTnT,而无HighT2患者中这一比例为66%(48/73)(p=0.002)。在hs-cTnT不可检测的情况下,仅4%(1/26)的患者出现HighT2。此外,HighT2的范围与hs-cTnT浓度升高相关(Spearman氏ρ:0.42,p<0.001)。
在这项针对HCM患者的CMR研究中,我们在四分之一的患者中观察到了HighT2,并证明HighT2与hs-cTnT升高相关。这一观察结果,结合hs-cTnT不可检测对HighT2的极高阴性预测价值,为HighT2表明近期发生的心肌细胞损伤这一假说提供了支持性证据。